Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy

Journal of Molecular Diagnostics

Volumn 15, Issue 2, 2013, Pages 270-279

  Dietrich, Dimo ^a   Hasinger, Oliver ^b   Bañez, Lionel L ^c,d   Sun, Leon ^c   Van Leenders, Geert J ^e   Wheeler, Thomas M ^f   Bangma, Chris H ^e   Wernert, Nicolas ^a   Perner, Sven ^a   Freedland, Stephen J ^c,d   Corman, John M ^g   Ittmann, Michael M ^f   Lark, Amy L ^c,d   Madden, John F ^c   Hartmann, Arndt ^h   Schatz, Philipp ⁱ   Kristiansen, Glen ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b EPIGENOMICS AG   (Germany)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g VIRGINIA MASON MEDICAL CENTER   (United States)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ Metanomics Health GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR PITX2;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CLINICAL PRACTICE; COHORT ANALYSIS; DNA METHYLATION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT; PROSTATE CANCER; PROSTATECTOMY; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; DNA METHYLATION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECURRENCE; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION FACTORS;

EID: 84874527353     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.11.002     Document Type: Article

References (28)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. F.H. Schröder, J. Hugosson, M.J. Roobol, T.L. Tammela, S. Ciatto, V. Nelen, M. Kwiatkowski, M. Lujan, H. Lilja, M. Zappa, L.J. Denis, F. Recker, A. Berenguer, L. Määttänen, C.H. Bangma, G. Aus, A. Villers, X. Rebillard, T. van der Kwast, B.G. Blijenberg, S.M. Moss, H.J. de Koning, A. Auvinen ERSPC Investigators Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
3. L. Klotz Active surveillance for prostate cancer: a review Arch Esp Urol 64 2011 806 814
4. L. Klotz Cancer overdiagnosis and overtreatment Curr Opin Urol 22 2012 203 209
5. M.W. Kattan, J.A. Eastham, A.M. Stapleton, T.M. Wheeler, and P.T. Scardino A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
6. D.D. De Carvalho, J.S. You, and P.A. Jones DNA methylation and cellular reprogramming Trends Cell Biol 20 2010 609 617
7. T.M. Geiman, and K. Muegge DNA methylation in early development Mol Reprod Dev 77 2010 105 113
8. N. Sinčić, and Z. Herceg DNA methylation and cancer: ghosts and angels above the genes Curr Opin Oncol 23 2011 69 76
9. M. Kulis, and M. Esteller DNA methylation and cancer Adv Genet 70 2010 27 56
10. D. Dietrich, O. Hasinger, V. Liebenberg, J.K. Field, G. Kristiansen, and A. Soltermann DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients Diagn Mol Pathol 21 2012 93 104
11. S. Maier, I. Nimmrich, T. Koenig, S. Eppenberger-Castori, I. Bohlmann, A. Paradiso, F. Spyratos, C. Thomssen, V. Mueller, J. Nährig, F. Schittulli, R. Kates, R. Lesche, I. Schwope, A. Kluth, A. Marx, J.W. Martens, J.A. Foekens, M. Schmitt, N. Harbeck European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients-Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group Eur J Cancer 43 2007 1679 1686
12. I. Nimmrich, A.M. Sieuwerts, M.E. Meijer-van Gelder, I. Schwope, J. Bolt-de Vries, N. Harbeck, T. Koenig, O. Hartmann, A. Kluth, D. Dietrich, V. Magdolen, H. Portengen, M.P. Look, J.G. Klijn, R. Lesche, M. Schmitt, S. Maier, J.A. Foekens, and J.W. Martens DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients Breast Cancer Res Treat 111 2008 429 437
13. N. Harbeck, I. Nimmrich, A. Hartmann, J.S. Ross, T. Cufer, R. Grützmann, G. Kristiansen, A. Paradiso, O. Hartmann, A. Margossian, J. Martens, I. Schwope, A. Lukas, V. Müller, K. Milde-Langosch, J. Nährig, J. Foekens, S. Maier, M. Schmitt, and R. Lesche Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients J Clin Oncol 26 2008 5036 5042
14. O. Hartmann, F. Spyratos, N. Harbeck, D. Dietrich, A. Fassbender, M. Schmitt, S. Eppenberger-Castori, V. Vuaroqueaux, F. Lerebours, K. Welzel, S. Maier, A. Plum, S. Niemann, J.A. Foekens, R. Lesche, and J.W. Martens DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy Clin Cancer Res 15 2009 315 323
15. G. Weiss, S. Cottrell, J. Distler, P. Schatz, G. Kristiansen, M. Ittmann, C. Haefliger, R. Lesche, A. Hartmann, J. Corman, and T. Wheeler DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy J Urol 181 2009 1678 1685
16. P. Schatz, D. Dietrich, T. Koenig, M. Burger, A. Lukas, I. Fuhrmann, G. Kristiansen, R. Stoehr, M. Schuster, R. Lesche, G. Weiss, J. Corman, and A. Hartmann Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation J Mol Diagn 12 2010 345 353
17. L.L. Bañez, L. Sun, G.J. van Leenders, T.M. Wheeler, C.H. Bangma, S.J. Freedland, M.M. Ittmann, A.L. Lark, J.F. Madden, A. Hartman, G. Weiss, and E. Castaños-Vélez Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer J Urol 184 2010 149 156
18. C.R. Lin, C. Kioussi, S. O'Connell, P. Briata, D. Szeto, F. Liu, J.C. Izpisúa-Belmonte, and M.G. Rosenfeld Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis Nature 401 1999 279 282
19. Y. Kato The multiple roles of Notch signaling during left-right patterning Cell Mol Life Sci 68 2011 2555 2567
20. T.C. Chang, C.G. Summers, L.A. Schimmenti, and A.L. Grajewski Axenfeld-Rieger syndrome: new perspectives Br J Ophthalmol 96 2012 318 322
21. H. Schayek, I. Bentov, J. Jacob-Hirsch, C. Yeung, C. Khanna, L.J. Helman, S.R. Plymate, and H. Werner Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer Horm Metab Res 44 2012 511 519
22. S.E. Cottrell, J. Distler, N.S. Goodman, S.H. Mooney, A. Kluth, A. Olek, I. Schwope, R. Tetzner, H. Ziebarth, and K. Berlin A real-time PCR assay for DNA-methylation using methylation-specific blockers Nucleic Acids Res 32 2004 e10
23. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
24. J. Winer, C.K. Jung, I. Shackel, and P.M. Williams Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro Anal Biochem 270 1999 41 49
25. D. Dietrich, C. Kneip, O. Raji, T. Liloglou, A. Seegebarth, T. Schlegel, N. Flemming, S. Rausch, J. Distler, M. Fleischhacker, B. Schmidt, T. Giles, M. Walshaw, C. Warburton, V. Liebenberg, and J.K. Field Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates Int J Oncol 40 2012 825 832
26. G. Kristiansen Diagnostic and prognostic molecular biomarkers for prostate cancer Histopathology 60 2012 125 141
27. V.L. Costa, R. Henrique, and C. Jerónimo Epigenetic markers for molecular detection of prostate cancer Dis Markers 23 2007 31 41
28. D. Dietrich, R. Lesche, R. Tetzner, M. Krispin, J. Dietrich, W. Haedicke, M. Schuster, and G. Kristiansen Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues J Histochem Cytochem 57 2009 477 489